Risk Stratification of Nonmuscle Invasive Bladder Cancer and Innovative Approaches to Management of Ta Low-Grade Tumors

被引：1
|
作者：
Kim, Sung Han [1 ,2 ]
Lerner, Seth P. P. [2 ,3 ]
机构：
[1] Natl Canc Ctr, Res Inst & Hosp, Dept Urol, Goyang, South Korea
[2] Baylor Coll Med, Dan L Duncan Canc Ctr, Scott Dept Urol, Houston, TX USA
[3] Baylor Coll Med Med Ctr, Fac Affairs, Scott Dept Urol, Beth & Dave Swalm Chair Urol Oncol, 7200 Cambridge,MC BCM380, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 02期
关键词：
INTRAVESICAL MITOMYCIN-C; DIAGNOSIS; EFFICACY;
D O I：
10.1200/JCO.22.02104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：163 / +
页数：5
相关论文
共 50 条
  • [31] High-Risk Nonmuscle Invasive Bladder Cancer
    Orsola, Anna
    Palou, Joan
    Solsona, Eduardo
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (02) : 227 - +
  • [32] Natural biology and management of nonmuscle invasive bladder cancer
    Scarpato, Kristen R.
    Tyson, Mark D.
    Clark, Peter E.
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (03) : 210 - 215
  • [33] Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer
    Rieken, Malte
    Shariat, Shahrokh F.
    Kluth, Luis
    Crivelli, Joseph J.
    Abufaraj, Mohammad
    Foerster, Beat
    Mari, Andrea
    Ilijazi, Dafina
    Karakiewicz, Pierre I.
    Babjuk, Marek
    Goenen, Mithat
    Xylinas, Evanguelos
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (01) : 8.e17 - 8.e24
  • [34] Therapeutic options in the management of intermediate-risk nonmuscle-invasive bladder cancer
    Horvath, Andras
    Mostafid, Hugh
    BJU INTERNATIONAL, 2009, 103 (06) : 726 - 729
  • [35] European Association of Urology and American Urological Association/Society of Urologic Oncology Guidelines on Risk Categories for Non-muscle-invasive Bladder Cancer May Lead to Overtreatment for Low-grade Ta Bladder Tumors
    Klaassen, Zachary
    Soloway, Mark S.
    UROLOGY, 2017, 105 : 14 - 17
  • [36] The Factors Affecting Recurrence and Prognosis in Patients with Low-grade Stage Ta Bladder Cancer
    Ozbek, Mustafa Latif
    Ozen, Mehmet
    Oner, Suleyman
    Kocamanoglu, Fatih
    Gulsen, Murat
    Mercimek, Mehmet Necmettin
    Bostanci, Yakup
    Sarikaya, Saban
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2021, 20 (01): : 40 - 44
  • [37] Bladder Herpes Infection in a Patient With Low-grade Non-Muscle-invasive Bladder Cancer
    Garrido-Abad, Pablo
    Diaz-Menendez, Ariel
    Fernandez-Arjona, Manuel
    UROLOGY, 2018, 112 : E1 - E2
  • [38] Office-based Management of Nonmuscle Invasive Bladder Cancer
    Meeks, Joshua J.
    Herr, Harry W.
    UROLOGIC CLINICS OF NORTH AMERICA, 2013, 40 (04) : 473 - +
  • [39] Emerging intravesical therapies for management of nonmuscle invasive bladder cancer
    Tomaszewski, Jeffrey J.
    Smaldone, Marc C.
    RESEARCH AND REPORTS IN UROLOGY, 2010, 2 : 67 - 84
  • [40] Principles for the Management of Nonmuscle Invasive Bladder Cancer (NMIBC) in 2015
    Neuzillet, Y.
    ONCOLOGIE, 2015, 17 (04) : 158 - 164
12345